Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 -5.16%83 Days Payable is 137.50 as of Mar. 2026, which is 7% below its 10-year median of 147.63. GuruFocus rates BOM:543350 with a GF Score™ of 83/100 and a GF Value™ of ₹1,192.28 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 73.68% on this metric.
The historical rank and industry rank for Vijaya Diagnostic Centre's Days Payable or its related term are showing as below:
BOM:543350'
s Days Payable Range Over the Past 10 Years
Min: 111.8 Med: 147.63 Max: 196.16
Current: 142.02
During the past 8 years, Vijaya Diagnostic Centre's highest Days Payable was 196.16. The lowest was 111.80. And the median was 147.63.
BOM:543350's Days Payable is ranked better than 73.68% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.64
vs BOM:543350: 142.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543350 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's Days Payable distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vijaya Diagnostic Centre's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaya Diagnostic Centre (BOM:543350) has a Days Payable of 137.50 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vijaya Diagnostic Centre and its competitors. This is near median its historical median of 147.63. Over the past decade, Vijaya Diagnostic Centre's Days Payable has ranged from 111.80 to 196.16. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #50 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 26.3%.
Is Vijaya Diagnostic Centre's Days Payable too high?
Vijaya Diagnostic Centre's current Days Payable of 137.50 is near median its 10-year median of 147.63. Over the past 10 years, this metric has ranged from a low of 111.80 to a high of 196.16. The Medical Diagnostics & Research industry median Days Payable is 64.64. Vijaya Diagnostic Centre's value of 137.50 is 112.7% above this industry median. Based on the distribution chart, Vijaya Diagnostic Centre ranks #50 out of 190 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Vijaya Diagnostic Centre has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #50 out of 190 companies for Days Payable. This puts Vijaya Diagnostic Centre in the upper half of its industry. The industry median Days Payable is 64.64. Vijaya Diagnostic Centre's value of 137.50 is 112.7% above this benchmark. Historically, Vijaya Diagnostic Centre's own Days Payable has ranged from 111.80 to 196.16 over the past decade. While the company's 10-year median is 147.63 vs. the industry median of 64.64, Vijaya Diagnostic Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaya Diagnostic Centre's current Days Payable of 137.50 is 112.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vijaya Diagnostic Centre and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaya Diagnostic Centre's current Days Payable is 137.50, which is near median its own 10-year median of 147.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,192.28, compared to a current price of ₹1,333.70 — trading 11.9% above its estimated fair value. The current Days Payable is 137.50, which is near median its 10-year median of 147.63 and 112.7% above the Medical Diagnostics & Research industry median of 64.64. Vijaya Diagnostic Centre's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current Days Payable is 137.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,333.70 is trading 11.9% above its estimated GF Value™ of ₹1,192.28.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
Days Payable: 137.50 (near median its 10-year median of 147.63)
GF Value™: ₹1,192.28 vs. price of ₹1,333.70 (11.9% above fair value)
Industry Position: 112.7% above the Medical Diagnostics & Research median (#50 of 190)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
83GF Score
Get the complete analysis for BOM:543350
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
